asthma
Conditions
Interventions
Control group:Placebo
Sponsors
Weihai Municipal Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: (1) aged 18~75 years old; (2) conforms to the diagnostic criteria of bronchial asthma; (3) during the non acute attack of asthma, the disease is temporarily stable and the drug can be controlled; (4) informed consent and voluntary participation in the study and the signing of informed consent.
Exclusion criteria
Exclusion criteria: (1) pregnant or lactation patients; (2) female patients who did not use any contraceptive measures; (3) unstable vital signs and unstable patients; (4) acute attack of bronchial asthma; (5) combined with active malignant tumors, stroke, myocardial infarction and other serious primary diseases; (6) there were gastrointestinal bleeding, irritable bowel syndrome, Crohn disease or ulcerative colitis, and gastrointestinal tract history; (7) patients with a history of psychosis; (8) patients who took antibiotics, glucocorticoids or other immunosuppressive agents, including probiotics, prebiotics, food and drugs in the past 1 months; (9) allergic reaction to the sample or obvious gastrointestinal symptoms such as intolerance; (10) the patients received other clinical trials at the same time; (11) those who were identified by the researchers could not finish the research in time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ACT questionnaire score;pulmonary function;FENO;Peripheral blood eosinophil count;IgE;Intestinal microflora determination;Determination of blood metabolites; | — |
Countries
China
Contacts
Public ContactLiu Ailing
Weihai Municipal Hospital
Outcome results
None listed